✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › Boceprevir

Boceprevir

CAS 394730-60-0C27H45N5O5MW 519.7

Boceprevir (CAS No. 394730-60-0) is supplied by Jinan Shenghe Chemical Co., Ltd. with a typical purity of 按批次COA提供(不公开发布). Main applications include Pharmaceutical Intermediates & APIs. Bulk quantities are available with COA; purity and packaging are subject to batch COA and order confirmation.

Product Overview

CAS Number394730-60-0
Molecular FormulaC27H45N5O5
Molecular Weight519.7
LogP3.1
Purity按批次COA提供(不公开发布)
Packaging按订单/批次确认(不公开发布)
ApplicationsPharmaceutical Intermediates & APIs
CategoryPharmaceutical Intermediates & APIs

Applications

Pharmaceutical Intermediates & APIs

Packaging & Storage

Packaging按订单/批次确认(不公开发布)
Purity按批次COA提供(不公开发布)
StorageSealed, cool and dry place
ShippingStandard chemical transport
SampleAvailable on request
Lead TimeIn stock / per order

Quality & Documentation

COA (Certificate of Analysis) is provided with every batch. MSDS/technical data sheets and third-party test reports are available on request. Purity and packaging are subject to batch COA and order confirmation.

Frequently Asked Questions

What is the CAS number of Boceprevir?

The CAS number of Boceprevir is 394730-60-0.

What purity and packaging are available?

Typical purity is 按批次COA提供(不公开发布), supplied in 按订单/批次确认(不公开发布), with COA provided.

What are the applications of Boceprevir?

Main applications include Pharmaceutical Intermediates & APIs.

How do I buy Boceprevir or get a quote?

Email info@591daili.com or reach us on WhatsApp with the product name, CAS number and required quantity; quotes within one business day. Supplier: Jinan Shenghe Chemical Co., Ltd..

PubChem Public Data

Description

Boceprevir · CAS 394730-60-0 · C27H45N5O5. UNII 89BT58KELH.

Identification

CAS Registry Number394730-60-0
PubChem CID10324367
Molecular formulaC27H45N5O5
IUPAC name(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
UNII (FDA)89BT58KELH

Computed Descriptors

Molecular Weight519.7
XLogP33.1
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count5
Rotatable Bond Count10
Exact Mass519.34206955
Monoisotopic Mass519.34206955
Topological Polar Surface Area151
Heavy Atom Count37
Formal Charge0

Physical description & handling notes

  • White to off-white amorphous powder
  • Slightly soluble in water
  • Freely soluble in methanol, ethanol, and isopropanol
  • Boceprevir is classified as a direct-acting antiviral (DAA) and prevents viral replication in HCV genotype 1.
  • VICTRELIS 200 mg Capsules, red-colored cap with the Merck logo printed in yellow ink, and a yellow-colored body with "314" printed in red ink.

GHS Hazard Classification

Reported hazard statementsH302 (92.9%), H361 (92.9%)

H302 (92.9%): Harmful if swallowed [Warning Acute toxicity, oral]

H361 (92.9%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]

Documented Uses

  • Manufactured as an approximately equal mixture of two diasteromers.
  • Boceprevir, when used in combination with [DB00811], [DB00008], and [DB00022] is indicated for use in the treatment of chronic HCV genotype 1 infection in adults.
  • Boceprevir is an oral, direct acting hepatitis C virus (HCV) protease inhibitor that was used in combination with peginterferon and ribavirin in the treatment of chronic hepatitis C, genotype 1. Initially approved for use in 2012, it was withdrawn in 2015 because of the availability of more effective and better tolerated all oral regimens of direct acting antiviral agents. Boceprevir was not linked to instances of acute liver injury during therapy but, when combined with peginterferon and ribavirin, was associated
  • Breast Feeding; Lactation; Milk, Human; Antiviral Agents; Protease Inhibitors
  • Boceprevir is indicated for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients (18 years and older) with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy. /Included in US product label/
  • Boceprevir must not be used as monotherapy and should only be used in combination with peginterferon alfa and ribavirin. /Included in US product label/

Synonyms

Boceprevir; 394730-60-0; Victrelis; SCH 503034; EBP 520; SCH-503034; SCH503034; EBP-520; 89BT58KELH; CHEBI:68621; boceprevirum; RefChem:56897; J05AP03; MFCD22208555; SCH 50304; Boceprevir(>90%)

Frequently Asked Questions

What are the CAS number and molecular formula of Boceprevir?

CAS 394730-60-0; molecular formula C27H45N5O5; molecular weight — g/mol.

What other names is Boceprevir known by?

Boceprevir, 394730-60-0, Victrelis, SCH 503034, EBP 520, SCH-503034.

Is Boceprevir classified as hazardous?

Hazard statements reported: H302, H361.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 波普瑞韦

鲁ICP备19031700号-2